FRONTIER · GLOBAL
Isomorphic Labs raises $5B for AI-driven drug discovery after Demis Hassabis departure from Google
Isomorphic Labs, founded by DeepMind co-founder Demis Hassabis, closed a $5B Series C round backed by Sequoia and Andreessen Horowitz. The company applies AI to molecular biology and drug development, independent of Hassabis's former role at Google.
WHY IT MATTERS · EDITORIAL ANALYSIS
Signals institutional capital rotation from pure LLM incumbents to applied AI in regulated biotech sectors. BFSI entities should monitor precedent for AI-driven compliance and risk modeling in life-sciences financing.
Source: CNBC · 2026-11-17